Table 2.

Selected front-line trials in younger patients

RegimenDrugDose, mg/m2AdministrationLength of cycle, d
RouteDays of
ABVD Doxorubicin 25 IV 1 and 15 28 
Bleomycin 10 IV 1 and 15  
Vinblastine* IV 1 and 15  
Dacarbazine 375 IV 1 and 15  
stdBEACOPP/BEACOPP-14 Bleomycin 10 IV 14-21 
Etoposide 100 IV 1-3  
Doxorubicin 25 IV  
Cyclophosphamide 650 IV  
Vincristine 1.4 IV  
Procarbazine 100 PO 1-7  
Prednisone 40-80 PO 1-14 or 1-7  
GCSF   9-13  
escBEACOPP Bleomycin 10 IV 21 
Etoposide 200 IV 1-3  
Doxorubicin 35 IV  
Cyclophosphamide 1200 IV  
Vincristine 1.4 IV  
Procarbazine 100 PO 1-7  
Prednisone 40 PO 1-14  
GCSF   Day 9 until recovery  
RegimenDrugDose, mg/m2AdministrationLength of cycle, d
RouteDays of
ABVD Doxorubicin 25 IV 1 and 15 28 
Bleomycin 10 IV 1 and 15  
Vinblastine* IV 1 and 15  
Dacarbazine 375 IV 1 and 15  
stdBEACOPP/BEACOPP-14 Bleomycin 10 IV 14-21 
Etoposide 100 IV 1-3  
Doxorubicin 25 IV  
Cyclophosphamide 650 IV  
Vincristine 1.4 IV  
Procarbazine 100 PO 1-7  
Prednisone 40-80 PO 1-14 or 1-7  
GCSF   9-13  
escBEACOPP Bleomycin 10 IV 21 
Etoposide 200 IV 1-3  
Doxorubicin 35 IV  
Cyclophosphamide 1200 IV  
Vincristine 1.4 IV  
Procarbazine 100 PO 1-7  
Prednisone 40 PO 1-14  
GCSF   Day 9 until recovery  

GCSF, granulocyte colony-stimulating factor; PO, oral administration; stdBEACOPP, standard BEACOPP. Other abbreviations are explained in Table 1.

*

Vinblastine is capped at 10 mg per administration.

Vincristine is capped at 2 mg per administration.

Prednisone is given as 40 mg from days 1 to 14 in stdBEACOPP and 80 mg from days 1 to 7 in BEACOPP-14.

Close Modal

or Create an Account

Close Modal
Close Modal